Ning Liao

Nanning, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Induction-phase blood arsenic concentration and relapse risk in pediatric acute promyelocytic leukemia treated with arsenic and all-trans retinoic acid.

Induction-phase blood arsenic concentration and relapse risk in pediatric acute promyelocytic leukemia treated with arsenic and all-trans retinoic acid.

Journal: Leukemia
Published: January 26, 2026

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Journal: Haematologica
Published: September 10, 2025

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood
Published: July 23, 2025

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood
Published: July 23, 2025

A multicenter study on the prognostic value of prednisone response in pediatric acute lymphoblastic leukemia.

A multicenter study on the prognostic value of prednisone response in pediatric acute lymphoblastic leukemia.

Journal: Annals of hematology
Published: February 08, 2025

Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 study.

Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 study.

Journal: British journal of haematology
Published: January 10, 2025

Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study.

Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study.

Journal: Cancer research and treatment
Published: January 30, 2024

Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study.

Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study.

Journal: European journal of haematology
Published: January 24, 2024

The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.

The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.

Journal: Hematological oncology
Published: July 03, 2023

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.

Journal: Hematology (Amsterdam, Netherlands)
Published: February 08, 2023

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia Group.

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia Group.

Journal: Frontiers in oncology
Published: May 14, 2022

A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.

A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.

Journal: Frontiers in oncology
Published: January 14, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026